(Q70124426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Prolonged survival in patients with beta-thalassemia major treated with deferoxamine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

main subject

beta-thalassemia major

1 reference

1 reference

Margaret W. Hilgartner

5

object named as

M W Hilgartner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

K H Ehlers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

P J Giardina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

M L Lesser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

M A Engle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

language of work or name

English

0 references

publication date

1 April 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

4 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

540-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

LATE CARDIAC COMPLICATIONS OF CHRONIC, SEVERE, REFRACTORY ANEMIA WITH HEMOCHROMATOSIS

8 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Longitudinal study of cardiac function in thalassemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Bone marrow transplantation in patients with thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Current strategies in the management of Cooley's anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Continuous subcutaenous administration of deferoxamine in patients with iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

A prospective evaluation of iron chelation therapy in children with severe beta-thalassemia. A six-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Early left ventricular dysfunction and chelation therapy in thalassemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Survival and desferrioxamine in thalassaemia major.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Survival and causes of death in thalassaemia major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983374-8

10.1016/S0022-3476(05)83374-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007928%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference